Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The release of the Open Payments data in the United States, which detail payments from pharmaceutical and medical device companies to physicians, enables analysis of the financial relationships between physicians and industry.1 However, the Physician Payments Sunshine Act, which mandates these disclosures, omits registered nurses. A recent qualitative study suggests nurse-industry interactions in US hospitals may be common and influential.2 The limited prevalence data available, based on self-report, suggests that 51% to 96% of nurses have contact with industry representatives.3
Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L. The Inclusion of Nurses in Pharmaceutical Industry–Sponsored EventsGuess Who Is Also Coming to Dinner?. JAMA Intern Med. Published online September 12, 2016. doi:10.1001/jamainternmed.2016.5276